Embryological origin of the endocardium and derived valve progenitor cells: From developmental biology to stem cell-based valve repair

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 4, 2013, Pages 917-922

  Pucéat, Michel ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Atrioventricular canal; EMT; Stem cell; Valvulogenesis

Indexed keywords

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; DEVELOPMENTAL BIOLOGY; EMBRYONIC STEM CELL; ENDOCARDIAL CELL; ENDOCARDIAL CUSHION; ENDOCARDIUM; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; ORGANOGENESIS; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; VALVULOGENESIS; VALVULOPLASTY;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINEAGE; DEVELOPMENTAL BIOLOGY; EMBRYONIC STEM CELLS; ENDOCARDIUM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART VALVES; HUMANS; MESODERM; MICE; ORGANOGENESIS; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

MUS;

EID: 84875061404     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.09.013     Document Type: Article

References (103)

1. Silverman M.E., Hurst J.W. The mitral complex. Interaction of the anatomy, physiology, and pathology of the mitral annulus, mitral valve leaflets, chordae tendineae, and papillary muscles. Am. Heart J. 1968, 76:399-418.
2. Silbiger J.J., Bazaz R. Contemporary insights into the functional anatomy of the mitral valve. Am. Heart J. 2009, 158:887-895.
3. Butcher J.T., Markwald R.R. Valvulogenesis: the moving target. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2007, 362:1489-1503.
4. Combs M.D., Yutzey K.E. Heart valve development: regulatory networks in development and disease. Circ. Res. 2009, 105:408-421.
5. Nkomo V.T., Gardin J.M., Skelton T.N., Gottdiener J.S., Scott C.G., Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006, 368:1005-1011.
6. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Makuc D.M., Marcus G.M., Marelli A., Matchar D.B., Moy C.S., Mozaffarian D., Mussolino M.E., Nichol G., Paynter N.P., Soliman E.Z., Sorlie P.D., Sotoodehnia N., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
7. Markwald R.R., Norris R.A., Moreno-Rodriguez R., Levine R.A. Developmental basis of adult cardiovascular diseases: valvular heart diseases. Ann. N. Y. Acad. Sci. 2010, 1188:177-183.
8. Padala M., Powell S.N., Croft L.R., Thourani V.H., Yoganathan A.P., Adams D.H. Mitral valve hemodynamics after repair of acute posterior leaflet prolapse: quadrangular resection versus triangular resection versus neochordoplasty. J. Thorac. Cardiovasc. Surg. 2009, 138:309-315.
9. Sewell-Loftin M.K., Chun Y.W., Khademhosseini A., Merryman W.D. EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology. J. Cardiovasc. Transl. Res. 2011, 4:658-671.
10. Butcher J.T., Mahler G.J., Hockaday L.A. Aortic valve disease and treatment: the need for naturally engineered solutions. Adv. Drug Deliv. Rev. 2011, 63:242-268.
11. Person A.D., Klewer S.E., Runyan R.B. Cell biology of cardiac cushion development. Int. Rev. Cytol. 2005, 243:287-335.
12. Eisenberg L.M., Markwald R.R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res. 1995, 77:1-6.
13. Milgrom-Hoffman M., Harrelson Z., Ferrara N., Zelzer E., Evans S.M., Tzahor E. The heart endocardium is derived from vascular endothelial progenitors. Development 2011, 138:4777-4787.
14. Narumiya H., Hidaka K., Shirai M., Terami H., Aburatani H., Morisaki T. Endocardiogenesis in embryoid bodies: novel markers identified by gene expression profiling. Biochem. Biophys. Res. Commun. 2007, 357:896-902.
15. Hatta S. Contribution to the morphology of cyclostomata. I. On the formation of the heart in petromyzon. J. Coll. Sci. Imp. Univ. Tokyo 1897, 10:225-237.
16. Tahara Y. Normal stages of development in the lamprey, Lampetra reissneri (Dybowski). Zool. Sci. 1988, 5:109-118.
17. Harris I.S., Black B.L. Development of the endocardium. Pediatr. Cardiol. 2010, 31:391-399.
18. Cohen-Gould L., Mikawa T. The fate diversity of mesodermal cells within the heart field during chicken early embryogenesis. Dev. Biol. 1996, 177:265-273.
19. Ishii Y., Langberg J., Rosborough K., Mikawa T. Endothelial cell lineages of the heart. Cell Tissue Res. 2009, 335:67-73.
20. Sugi Y., Markwald R.R. Early endocardial formation originates from precardiac mesoderm as revealed by QH-1 antibody staining. Ital. J. Anat. Embryol. 1995, 100(Suppl. 1):263-272.
21. Lough G., Sugi Y. Endoderm and heart development. Dev. Dyn. 2000, 327-342.
22. Ema M., Takahashi S., Rossant J. Deletion of the selection cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent mesodermal progenitors. Blood 2006, 107:111-117.
23. Cai C.L., Liang X., Shi Y., Chu P.H., Pfaff S.L., Chen J., Evans S. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 2003, 5:877-889.
24. Moretti A., Caron L., Nakano A., Lam J.T., Bernshausen A., Chen Y., Qyang Y., Bu L., Sasaki M., Martin-Puig S., Sun Y., Evans S.M., Laugwitz K.L., Chien K.R. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006, 127:1151-1165.
25. Verzi M.P., McCulley D.J., De Val S., Dodou E., Black B.L. The right ventricle, outflow tract, and ventricular septum comprise a restricted expression domain within the secondary/anterior heart field. Dev. Biol. 2005, 287:134-145.
26. Ferdous A., Caprioli A., Iacovino M., Martin C.M., Morris J., Richardson J.A., Latif S., Hammer R.E., Harvey R.P., Olson E.N., Kyba M., Garry D.J. Nkx2-5 transactivates the Ets-related protein 71 gene and specifies an endothelial/endocardial fate in the developing embryo. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:814-819.
27. Rasmussen T.L., Kweon J., Diekmann M.A., Belema-Bedada F., Song Q., Bowlin K., Shi X., Ferdous A., Li T., Kyba M., Metzger J.M., Koyano-Nakagawa N., Garry D.J. ER71 directs mesodermal fate decisions during embryogenesis. Development 2011, 138:4801-4812.
28. Krug E.L., Mjaatvedt C.H., Markwald R.R. Extracellular matrix from embryonic myocardium elicits an early morphogenetic event in cardiac endothelial differentiation. Dev. Biol. 1987, 120:348-355.
29. Suzuki H.R., Solursh M., Baldwin H.S. Relationship between fibronectin expression during gastrulation and heart formation in the rat embryo. Dev. Dyn. 1995, 204:259-277.
30. Aleksandrova A., Czirok A., Szabo A., Filla M.B., Hossain M.J., Whelan P.F., Lansford R., Rongish B.J. Convective tissue movements play a major role in avian endocardial morphogenesis. Dev. Biol. 2012, 363:348-361.
31. Fontana L., Chen Y., Prijatelj P., Sakai T., Fassler R., Sakai L.Y., Rifkin D.B. Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1. FASEB J. 2005, 19:1798-1808.
32. Wijelath E.S., Murray J., Rahman S., Patel Y., Ishida A., Strand K., Aziz S., Cardona C., Hammond W.P., Savidge G.F., Rafii S., Sobel M. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ. Res. 2002, 91:25-31.
33. Gittenberger-de Groot A.C., Vrancken Peeters M.P., Mentink M.M., Gourdie R.G., Poelmann R.E. Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. Circ. Res. 1998, 82:1043-1052.
34. Perez-Pomares J.M., Phelps A., Sedmerova M., Carmona R., Gonzalez-Iriarte M., Munoz-Chapuli R., Wessels A. Experimental studies on the spatiotemporal expression of WT1 and RALDH2 in the embryonic avian heart: a model for the regulation of myocardial and valvuloseptal development by epicardially derived cells (EPDCs). Dev. Biol. 2002, 247:307-326.
35. Wessels A., van den Hoff M.J., Adamo R.F., Phelps A.L., Lockhart M.M., Sauls K., Briggs L.E., Norris R.A., van Wijk B., Perez-Pomares J.M., Dettman R.W., Burch J.B. Epicardially derived fibroblasts preferentially contribute to the parietal leaflets of the atrioventricular valves in the murine heart. Dev. Biol. 2012, 366:111-124.
36. de Lange F.J., Moorman A.F., Anderson R.H., Manner J., Soufan A.T., de Gier-de Vries C., Schneider M.D., Webb S., van den Hoff M.J., Christoffels V.M. Lineage and morphogenetic analysis of the cardiac valves. Circ. Res. 2004, 95:645-654.
37. Tzouanacou E., Wegener A., Wymeersch F.J., Wilson V., Nicolas J.F. Redefining the progression of lineage segregations during mammalian embryogenesis by clonal analysis. Dev. Cell 2009, 17:365-376.
38. Buckingham M.E., Meilhac S.M. Tracing cells for tracking cell lineage and clonal behavior. Dev. Cell 2011, 21:394-409.
39. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
40. Funayama N., Sato Y., Matsumoto K., Ogura T., Takahashi Y. Coelom formation: binary decision of the lateral plate mesoderm is controlled by the ectoderm. Development 1999, 126:4129-4138.
41. Kruithof B.P., Duim S.N., Moerkamp A.T., Goumans M.J. TGFbeta and BMP signaling in cardiac cushion formation: lessons from mice and chicken. Differentiation 2012, 84:89-102.
42. de la Pompa J.L., Epstein J.A. Coordinating tissue interactions: Notch signaling in cardiac development and disease. Dev. Cell 2012, 22:244-254.
43. Azhar M., Brown K., Gard C., Chen H., Rajan S., Elliott D.A., Stevens M.V., Camenisch T.D., Conway S.J., Doetschman T. Transforming growth factor Beta2 is required for valve remodeling during heart development. Dev. Dyn. 2011, 240:2127-2141.
44. Harrelson Z., Kelly R.G., Goldin S.N., Gibson-Brown J.J., Bollag R.J., Silver L.M., Papaioannou V.E. Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development. Development 2004, 131:5041-5052.
45. Shirai M., Imanaka-Yoshida K., Schneider M.D., Schwartz R.J., Morisaki T. T-box 2, a mediator of Bmp-Smad signaling, induced hyaluronan synthase 2 and Tgfbeta2 expression and endocardial cushion formation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:18604-18609.
46. Kokubo N., Matsuura M., Onimaru K., Tiecke E., Kuraku S., Kuratani S., Tanaka M. Mechanisms of heart development in the Japanese lamprey, Lethenteron japonicum. Evol. Dev. 2010, 12:34-44.
47. Conway S.J., Doetschman T., Azhar M. The inter-relationship of periostin, TGF beta, and BMP in heart valve development and valvular heart diseases. ScientificWorldJournal 2011, 11:1509-1524.
48. Runyan R.B., Markwald R.R. Invasion of mesenchyme into three-dimensional collagen gels: a regional and temporal analysis of interaction in embryonic heart tissue. Dev. Biol. 1983, 95:108-114.
49. Lagendijk A.K., Goumans M.J., Burkhard S.B., Bakkers J. MicroRNA-23 restricts cardiac valve formation by inhibiting Has2 and extracellular hyaluronic acid production. Circ. Res. 2011, 109:649-657.
50. Nadeau M., Georges R.O., Laforest B., Yamak A., Lefebvre C., Beauregard J., Paradis P., Bruneau B.G., Andelfinger G., Nemer M. An endocardial pathway involving Tbx5, Gata4, and Nos3 required for atrial septum formation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:19356-19361.
51. Egorova A.D., Khedoe P.P., Goumans M.J., Yoder B.K., Nauli S.M., ten Dijke P., Poelmann R.E., Hierck B.P. Lack of primary cilia primes shear-induced endothelial-to-mesenchymal transition. Circulation 2011, 108:1093-1101.
52. Butcher J.T., Simmons C.A., Warnock J.N. Mechanobiology of the aortic heart valve. J. Heart Valve Dis. 2008, 17:62-73.
53. Buskohl P.R., Gould R.A., Butcher J.T. Quantification of embryonic atrioventricular valve biomechanics during morphogenesis. J. Biomech. 2012, 45:895-902.
54. Chen L., Ma Y., Kim E.Y., Yu W., Schwartz R.J., Qian L., Wang J. Conditional ablation of Ezh2 in murine hearts reveals its essential roles in endocardial cushion formation, cardiomyocyte proliferation and survival. PLoS One 2012, 7:e31005.
55. McDonald O.G., Wu H., Timp W., Doi A., Feinberg A.P. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat. Struct. Mol. Biol. 2011, 18:867-874.
56. Wu C.Y., Tsai Y.P., Wu M.Z., Teng S.C., Wu K.J. Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Trends Genet. 2012, 28:454-463.
57. Lincoln J., Alfieri C.M., Yutzey K.E. BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. Dev. Biol. 2006, 292:292-302.
58. Leschik J., Stefanovic S., Brinon B., Puceat M. Cardiac commitment of primate embryonic stem cells. Nat. Protoc. 2008, 3:1381-1387.
59. Blin G., Nury D., Stefanovic S., Neri T., Guillevic O., Brinon B., Bellamy V., Rucker-Martin C., Barbry P., Bel A., Bruneval P., Cowan C., Pouly J., Mitalipov S., Gouadon E., Binder P., Hagege A., Desnos M., Renaud J., Menasche P., Puceat M. A purified population of multipotent cardiovascular progenitors derived from primate embryonic stem cells engraft in postmyocardial infarcted non human primate. J. Clin. Invest. 2010, 120:1125-1139.
60. Stefanovic S., Abboud N., Desilets S., Nury D., Cowan C., Puceat M. Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. J. Cell Biol. 2009, 186:665-673.
61. Puceat M. Pluripotent stem cells: a cell model for early cardiac development. Biol Aujourdhui 2012, 206:25-29.
62. Guy T.S., Hill A.C. Mitral valve prolapse. Annu. Rev. Med. 2012, 63:277-292.
63. Dijkman P.E., Driessen-Mol A., Frese L., Hoerstrup S.P., Baaijens F.P. Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno- and homografts. Biomaterials 2012, 33:4545-4554.
64. Schmidt D., Achermann J., Odermatt B., Breymann C., Mol A., Genoni M., Zund G., Hoerstrup S.P. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 2007, 116:I64-I70.
65. Jordan J.E., Williams J.K., Lee S.J., Raghavan D., Atala A., Yoo J.J. Bioengineered self-seeding heart valves. J. Thorac. Cardiovasc. Surg. 2012, 143:201-208.
66. Gerson C.J., Elkins R.C., Goldstein S., Heacox A.E. Structural integrity of collagen and elastin in SynerGraft(R) decellularized-cryopreserved human heart valves. Cryobiology 2012, 64:33-42.
67. Harken D.E. Heart valves: ten commandments and still counting. Ann. Thorac. Surg. 1989, 48:S18-S19.
68. Neuenschwander S., Hoerstrup S.P. Heart valve tissue engineering. Transpl. Immunol. 2004, 12:359-365.
69. Schmidt D., Mol A., Kelm J.M., Hoerstrup S.P. In vitro heart valve tissue engineering. Methods Mol. Med. 2007, 140:319-330.
70. Chen Q., Chen H., Zheng D., Kuang C., Fang H., Zou B., Zhu W., Bu G., Jin T., Wang Z., Zhang X., Chen J., Field L.J., Rubart M., Shou W., Chen Y. Smad7 is required for the development and function of the heart. J. Biol. Chem. 2009, 284:292-300.
71. Song L., Zhao M., Wu B., Zhou B., Wang Q., Jiao K. Cell autonomous requirement of endocardial Smad4 during atrioventricular cushion development in mouse embryos. Dev. Dyn. 2011, 240:211-220.
72. Rivera-Feliciano J., Lee K.H., Kong S.W., Rajagopal S., Ma Q., Springer Z., Izumo S., Tabin C.J., Pu W.T. Development of heart valves requires Gata4 expression in endothelial-derived cells. Development 2006, 133:3607-3618.
73. Mjaatvedt C.H., Yamamura H., Capehart A.A., Turner D., Markwald R.R. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev. Biol. 1998, 202:56-66.
74. Oka C., Nakano T., Wakeham A., de la Pompa J.L., Mori C., Sakai T., Okazaki S., Kawaichi M., Shiota K., Mak T.W., Honjo T. Disruption of the mouse RBP-J kappa gene results in early embryonic death. Development 1995, 121:3291-3301.
75. Desgrosellier J.S., Mundell N.A., McDonnell M.A., Moses H.L., Barnett J.V. Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev. Biol. 2005, 280:201-210.
76. Wang J., Sridurongrit S., Dudas M., Thomas P., Nagy A., Schneider M.D., Epstein J.A., Kaartinen V. Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart. Dev. Biol. 2005, 286:299-310.
77. Ma L., Lu M.F., Schwartz R.J., Martin J.F. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 2005, 132:5601-5611.
78. Yamagishi T., Ando K., Nakamura H. Roles of TGFbeta and BMP during valvulo-septal endocardial cushion formation. Anat. Sci. Int. 2009, 84:77-87.
79. Song L., Fassler R., Mishina Y., Jiao K., Baldwin H.S. Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. Dev. Biol. 2007, 301:276-286.
80. Kruithof B.P., Duim S.N., Moerkamp A.T., Goumans M.J. TGFbeta and BMP signaling in cardiac cushion formation: lessons from mice and chicken. Differentiation 2012, 84:89-102.
81. Nakajima Y., Yamagishi T., Hokari S., Nakamura H. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat. Rec. 2000, 258:119-127.
82. Gu H., Smith F.C., Taffet S.M., Delmar M. High incidence of cardiac malformations in connexin40-deficient mice. Circ. Res. 2003, 93:201-206.
83. Kumai M., Nishii K., Nakamura K., Takeda N., Suzuki M., Shibata Y. Loss of connexin45 causes a cushion defect in early cardiogenesis. Development 2000, 127:3501-3512.
84. Sakata Y., Koibuchi N., Xiang F., Youngblood J.M., Kamei C.N., Chin M.T. The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation. J. Mol. Cell. Cardiol. 2006, 40:267-273.
85. Webb S., Anderson R.H., Brown N.A. Endocardial cushion development and heart loop architecture in the trisomy 16 mouse. Dev. Dyn. 1996, 206:301-309.
86. Kurohara K., Komatsu K., Kurisaki T., Masuda A., Irie N., Asano M., Sudo K., Nabeshima Y., Iwakura Y., Sehara-Fujisawa A. Essential roles of Meltrin beta (ADAM19) in heart development. Dev. Biol. 2004, 267:14-28.
87. Krenz M., Gulick J., Osinska H.E., Colbert M.C., Molkentin J.D., Robbins J. Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:18930-18935.
88. Shelton E.L., Yutzey K.E. Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression. Dev. Biol. 2007, 302:376-388.
89. Bourdeau A., Dumont D.J., Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 1999, 104:1343-1351.
90. Lee M.P., Yutzey K.E. Twist1 directly regulates genes that promote cell proliferation and migration in developing heart valves. PLoS One 2011, 6:e29758.
91. Akiyama H., Chaboissier M.C., Behringer R.R., Rowitch D.H., Schedl A., Epstein J.A., de Crombrugghe B. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6502-6507.
92. Feng Q., Di R., Tao F., Chang Z., Lu S., Fan W., Shan C., Li X., Yang Z. PDK1 regulates vascular remodeling and promotes epithelial-mesenchymal transition in cardiac development. Mol. Cell. Biol. 2010, 30:3711-3721.
93. Flagg A.E., Earley J.U., Svensson E.C. FOG-2 attenuates endothelial-to-mesenchymal transformation in the endocardial cushions of the developing heart. Dev. Biol. 2007, 304:308-316.
94. Tao G., Levay A.K., Gridley T., Lincoln J. Mmp15 is a direct target of Snai1 during endothelial to mesenchymal transformation and endocardial cushion development. Dev. Biol. 2011, 359:209-221.
95. Chen Y.H., Ishii M., Sun J., Sucov H.M., Maxson R.E. Msx1 and Msx2 regulate survival of secondary heart field precursors and post-migratory proliferation of cardiac neural crest in the outflow tract. Dev. Biol. 2007, 308:421-437.
96. Galvin K.M., Donovan M.J., Lynch C.A., Meyer R.I., Paul R.J., Lorenz J.N., Fairchild-Huntress V., Dixon K.L., Dunmore J.H., Gimbrone M.A., Falb D., Huszar D. A role for smad6 in development and homeostasis of the cardiovascular system. Nat. Genet. 2000, 24:171-174.
97. Niessen K., Fu Y., Chang L., Hoodless P.A., McFadden D., Karsan A. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J. Cell Biol. 2008, 182:315-325.
98. Gaborit N., Sakuma R., Wylie J.N., Kim K.H., Zhang S.S., Hui C.C., Bruneau B.G. Cooperative and antagonistic roles for Irx3 and Irx5 in cardiac morphogenesis and postnatal physiology. Development 2012, 139. 4007-19.
99. Gruber P.J., Kubalak S.W., Pexieder T., Sucov H.M., Evans R.M., Chien K.R. RXR alpha deficiency confers genetic susceptibility for aortic sac, conotruncal, atrioventricular cushion, and ventricular muscle defects in mice. J. Clin. Invest. 1996, 98:1332-1343.
100. Davis L.A., Sadler T.W. Effects of vitamin A on endocardial cushion development in the mouse heart. Teratology 1981, 24:139-148.
101. Bouman H.G., Broekhuizen M.L., Baasten A.M., Gittenberger-de Groot A.C., Wenink A.C. Diminished growth of atrioventricular cushion tissue in stage 24 retinoic acid-treated chicken embryos. Dev. Dyn. 1998, 213:50-58.
102. Yasui H., Morishima M., Nakazawa M., Aikawa E. Anomalous looping, atrioventricular cushion dysplasia, and unilateral ventricular hypoplasia in the mouse embryos with right isomerism induced by retinoic acid. Anat. Rec. 1998, 250:210-219.
103. Stevens M.V., Parker P., Vaillancourt R.R., Camenisch T.D. MEKK4 regulates developmental EMT in the embryonic heart. Dev. Dyn. 2006, 235:2761-2770.